AAAAAA

   
Results: 1-11 |
Results: 11
Differential metabolism of human VLDL according to content of ApoE and ApoC-III
Authors: Tomiyasu, K Walsh, BW Ikewaki, K Judge, H Sacks, FM
Citation: K. Tomiyasu et al., Differential metabolism of human VLDL according to content of ApoE and ApoC-III, ART THROM V, 21(9), 2001, pp. 1494-1500
Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women
Authors: Anderson, PW Cox, DA Sashegyi, A Paul, S Silfen, SL Walsh, BW
Citation: Pw. Anderson et al., Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women, MATURITAS, 39(1), 2001, pp. 71-77
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women
Authors: Walsh, BW Cox, DA Sashegyi, A Dean, RA Tracy, RP Anderson, PW
Citation: Bw. Walsh et al., Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women, AM J CARD, 88(7), 2001, pp. 825
A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium
Authors: Goldstein, SR Scheele, WH Rajagopalan, SK Wilkie, JL Walsh, BW Parsons, AK
Citation: Sr. Goldstein et al., A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium, OBSTET GYN, 95(1), 2000, pp. 95-103
Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women
Authors: Downs, RW Bell, NH Ettinger, MP Walsh, BW Favus, MJ Mako, B Wang, LX Smith, ME Gormley, GJ Melton, ME
Citation: Rw. Downs et al., Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women, J CLIN END, 85(5), 2000, pp. 1783-1788
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial
Authors: Walsh, BW Paul, S Wild, RA Dean, RA Tracy, RP Cox, DA Anderson, PW
Citation: Bw. Walsh et al., The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: A randomized, controlled trial, J CLIN END, 85(1), 2000, pp. 214-218
Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women
Authors: Seely, EW Walsh, BW Gerhard, MD Williams, GH
Citation: Ew. Seely et al., Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women, HYPERTENSIO, 33(5), 1999, pp. 1190-1194
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial
Authors: Lindsay, R Cosman, F Lobo, RA Walsh, BW Harris, ST Reagan, JE Liss, CL Melton, ME Byrnes, CA
Citation: R. Lindsay et al., Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial, J CLIN END, 84(9), 1999, pp. 3076-3081
The individualized approach to menopause management
Authors: Walsh, BW
Citation: Bw. Walsh, The individualized approach to menopause management, J CLIN END, 84(6), 1999, pp. 1900-1904
Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol
Authors: Walsh, BW Spiegelman, D Morrissey, M Sacks, FM
Citation: Bw. Walsh et al., Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol, J CLIN END, 84(3), 1999, pp. 985-989
The use of antiestrogens in the postmenopausal woman
Authors: Leondires, MP Segars, JH Walsh, BW
Citation: Mp. Leondires et al., The use of antiestrogens in the postmenopausal woman, CONT ENDOC, 18, 1999, pp. 179-207
Risultati: 1-11 |